McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,061.69 10.31 −0.96%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 4 Nov
P/E ratio

+8 more quarters

23.49 22.40 20.13 21.86
P/S ratio
0.25 0.27 0.22 0.24
P/FCF ratio
10.48 19.77 14.60 14.46
P/Operating CF
82.03 31.27 (407.68) 32.34
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
0.28 0.28 0.24 0.25
EV/EBITDA
17.32 16.51 13.68 14.27
EV/FCF
11.38 21.18 16.16 15.51
Current Ratio
0.88 0.85 0.89 0.90
Net Debt/EBITDA
4.82 3.26 6.36 4.02
Debt/Equity
(12.94) (6.54) (3.83) (3.85)
Earnings Yield
4.26% 4.47% 4.97% 4.57%
Free Cash Flow Yield
9.54% 5.06% 6.85% 6.92%
Free Cash Flow per Share
8.58 26.18 (3.13) 25.34
Book value per Share
(7.31) (14.38) (32.55) (30.77)
Free Cash Flow
1,057.00 3,236.00 (372.00) 2,947.00
EV/EBIT
19.42 18.45 15.29 15.92
Other line items

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026